» Authors » Nikos Prapas

Nikos Prapas

Explore the profile of Nikos Prapas including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 392
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Dinicola S, Unfer V, Soulage C, Yap-Garcia M, Bevilacqua A, Benvenga S, et al.
Gynecol Obstet Invest . 2024 Feb; 89(4):284-294. PMID: 38373412
Background: <sc>d</sc>-Chiro-inositol is a natural molecule that, in association with its well-studied isomer myo-inositol, may play a role in treating various metabolic and gynecological disorders. Objectives: This perspective seeks to...
2.
Dinicola S, Unfer V, Facchinetti F, Soulage C, Greene N, Bizzarri M, et al.
Int J Mol Sci . 2021 Oct; 22(19). PMID: 34638926
Myo-inositol (myo-Ins) and D-chiro-inositol (D-chiro-Ins) are natural compounds involved in many biological pathways. Since the discovery of their involvement in endocrine signal transduction, myo-Ins and D-chiro-Ins supplementation has contributed to...
3.
Facchinetti F, Espinola M, Dewailly D, Ozay A, Prapas N, Vazquez-Levin M, et al.
Trends Endocrinol Metab . 2020 May; 31(8):570-579. PMID: 32418772
It is well known that myo-inositol (MI) and D-chiro-inositol (DCI) are insulin-sensitizing agents, and MI is of proven utility in polycystic ovary syndrome (PCOS). In addition, MI plays a pivotal...
4.
Prapas Y, Zikopoulos A, Petousis S, Xiromeritis P, Tinelli A, Ravanos K, et al.
Eur J Obstet Gynecol Reprod Biol . 2020 Apr; 248:204-210. PMID: 32283430
Study Objective: To evaluate surgical outcomes of intracapsular single-layer myomectomy in terms of efficacy and safety as well as examine potential alterations based on kind of surgical approach. Methods: A...
5.
Facchinetti F, Appetecchia M, Aragona C, Bevilacqua A, Espinola M, Bizzarri M, et al.
Expert Opin Drug Metab Toxicol . 2020 Mar; 16(3):255-274. PMID: 32129111
: This Experts' opinion provides an updated scientific support to gynecologists, obstetricians, endocrinologists, nutritionists, neurologists and general practitioners on the use of Inositols in the therapy of Polycystic Ovary Syndrome...
6.
Chatzimeletiou K, Vanderzwalmen P, Panagiotidis Y, Papatheodorou A, Karagiannidis A, Kolibianakis E, et al.
Zygote . 2019 May; 27(3):153-159. PMID: 31060631
SummaryThe aim of this study was to investigate the effects of zona drilling and biopsy on day 3 followed by vitrification on day 5 on the cytoskeleton and development of...
7.
Antonouli S, Papatheodorou A, Panagiotidis Y, Petousis S, Prapas N, Nottola S, et al.
Arch Gynecol Obstet . 2019 Apr; 300(1):207-215. PMID: 30941554
Purpose: The aim of this study is to evaluate the sperm DNA fragmentation index (DFI) in oocyte donation cycles and correlate it with the sperm parameters, the male characteristics, the...
8.
Ravanos K, Petousis S, Margioula-Siarkou C, Papatheodorou A, Panagiotidis Y, Prapas N, et al.
Obstet Gynecol Surv . 2018 Nov; 73(10):595-605. PMID: 30379321
Importance: Temporal global trends of sperm quality remain a matter of debate. Objective: The aim of this study was to present a comprehensive review of studies reporting on sperm quality...
9.
Unfer V, Nestler J, Kamenov Z, Prapas N, Facchinetti F
Int J Endocrinol . 2018 Feb; 2017:6451082. PMID: 29445397
[This corrects the article DOI: 10.1155/2017/8515703.].
10.
Prapas Y, Ravanos K, Petousis S, Panagiotidis Y, Papatheodorou A, Margioula-Siarkou C, et al.
J Assist Reprod Genet . 2017 Aug; 34(11):1537-1545. PMID: 28776117
Purpose: The purpose this study is to investigate whether a double antagonist dose (0.25 mg/12 h) administered the day before hCG trigger is effective in preventing ovarian hyperstimulation syndrome (OHSS)...